G
GWPH

Gainplan’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Gainplan’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,000
Closed -$345K – 67
2019
Q3 		$345K Buy
+3,000
New +$455K 0.21% 25
2017
Q4 		– Sell
-3,000
Closed -$304K – 24
2017
Q3 		$304K Buy
+3,000
New +$321K 0.16% 5

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MGIM
M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Gainplan's GWPH Position: Q4 2019 in Review

Gainplan sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 3,000 shares — an estimated $345K sold.

Gainplan first reported a position in GWPH in Q3 2017 and held it in 2 quarters. The position peaked at $345K in Q3 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

  • Gainplan reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • Gainplan sold 3,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $345K.
  • Gainplan first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2017 and held it in 2 quarters.
  • Gainplan's GW Pharmaceuticals Plc American Depositary Shares position peaked at $345K in Q3 2019.
  • 318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on Gainplan's 13F filing for Q4 2019, filed 15 Jan 2020.